These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31155488)

  • 21. The Silencing of SFRP2 Expression in ESCC Is Due to Methylation of the Gene Promoter.
    Liu Q; Zhou YX; Hui-Wang ; Li QX; Wu M; Ma YQ
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819877977. PubMed ID: 31578133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LINE-1 hypomethylation is associated with a poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
    Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Sakamaki K; Ohashi Y; Baba H
    Ann Surg; 2013 Mar; 257(3):449-55. PubMed ID: 23023202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic modulation combined with PD-1/PD-L1 blockade enhances immunotherapy based on MAGE-A11 antigen-specific CD8+T cells against esophageal carcinoma.
    Wu Y; Sang M; Liu F; Zhang J; Li W; Li Z; Gu L; Zheng Y; Li J; Shan B
    Carcinogenesis; 2020 Jul; 41(7):894-903. PubMed ID: 32529260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.
    Qian Z; Wei B; Zhou Y; Wang Q; Wang J; Sun Y; Gao Y; Chen X
    BMC Cancer; 2019 Jun; 19(1):585. PubMed ID: 31200670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Guo YL; Shan BE; Guo W; Dong ZM; Zhou Z; Shen SP; Guo X; Liang J; Kuang G
    J Biomed Sci; 2017 Jan; 24(1):6. PubMed ID: 28077137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.
    Sheyhidin I; Hasim A; Zheng F; Ma H
    Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of melanoma-associated antigen D4 is an independent prognostic factor in squamous cell carcinoma of the esophagus.
    Oya H; Kanda M; Takami H; Hibino S; Shimizu D; Niwa Y; Koike M; Nomoto S; Yamada S; Nishikawa Y; Asai M; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Dis Esophagus; 2015; 28(2):188-95. PubMed ID: 24147998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Liu Z; Yang T; Xu Z; Cao X
    Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
    Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y
    Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Baba H; Kanda M; Sawaki K; Shimizu D; Umeda S; Koike M; Kodera Y; Fujii T
    Anticancer Res; 2019 Nov; 39(11):5943-5951. PubMed ID: 31704819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-DRB1 and HLA-DQB1 methylation changes promote the occurrence and progression of Kazakh ESCC.
    Hu JM; Li L; Chen YZ; Liu C; Cui X; Yin L; Yang L; Zou H; Pang L; Zhao J; Qi Y; Cao Y; Jiang J; Liang W; Li F
    Epigenetics; 2014 Oct; 9(10):1366-73. PubMed ID: 25437052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
    Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
    Li P; Liu X; Dong ZM; Ling ZQ
    Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA PANDA promotes esophageal squamous carcinoma cell progress by dissociating from NF-YA but interact with SAFA.
    Shi W; Wang Q; Bian Y; Fan Y; Zhou Y; Feng T; Li Z; Cao X
    Pathol Res Pract; 2019 Oct; 215(10):152604. PubMed ID: 31495606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma.
    Nakamura K; Baba Y; Kosumi K; Harada K; Shigaki H; Miyake K; Kiyozumi Y; Ohuchi M; Kurashige J; Ishimoto T; Iwatsuki M; Sakamoto Y; Yoshida N; Watanabe M; Nakao M; Baba H
    Oncotarget; 2016 Sep; 7(36):57821-57831. PubMed ID: 27507047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma.
    Chen Y; Zhang C; Chen J; Zhang B; Zhang H; Yang X; Liu J; Wu Q
    Med Sci Monit; 2018 Jun; 24():4128-4136. PubMed ID: 29909422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RHCG Suppresses Tumorigenicity and Metastasis in Esophageal Squamous Cell Carcinoma via Inhibiting NF-κB Signaling and MMP1 Expression.
    Ming XY; Zhang X; Cao TT; Zhang LY; Qi JL; Kam NW; Tang XM; Cui YZ; Zhang BZ; Li Y; Qin YR; Guan XY
    Theranostics; 2018; 8(1):185-198. PubMed ID: 29290801
    [No Abstract]   [Full Text] [Related]  

  • 40. Chromosomal instability associated with global DNA hypomethylation is associated with the initiation and progression of esophageal squamous cell carcinoma.
    Kawano H; Saeki H; Kitao H; Tsuda Y; Otsu H; Ando K; Ito S; Egashira A; Oki E; Morita M; Oda Y; Maehara Y
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S696-702. PubMed ID: 24898425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.